A lack of consensus guidelines or a belief that current evidence does not support such guidelines might be justified if a clinician expresses a commitment to patient-centered care and shared decision making.

Procedures for weighing factual evidence could help avoid the epistemic injustice of discounting or ignoring the voices of clinical research subjects.

The DSM-5 Task Force’s handling of the ethical controversy over the bereavement exclusion demonstrates the need for more inclusive deliberative processes.

Corporatization in health care has complicated clinicians’ and organizations’ efforts to balance interests of individual patients against an organization’s bottom line.

Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky.

Government-supported review and safety monitoring is needed for dietary supplements’ use in the care of patients with mental illness.

Dr Katherine Wu joins Ethics Talk to discuss her article, coauthored with Dr Erik Messamore: “Reimagining Roles of Dietary Supplements in Psychiatric Care.”

What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early?

The question of whether and how results from personal genetic testing will motivate behavioral changes in consumers has only begun to receive the research attention it richly deserves.

Clinicians can be patient advocates, resource stewards, and promote good financial choices about care.